Mary Thistle - 13 Jun 2024 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
4
Filing time
14 Jun 2024, 16:36:31 UTC
Previous filing
07 Jun 2024
Next filing
09 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 13 Jun 2024 Common Stock 16,000 $16.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 13, 2024 or (ii) the Issuer's next annual meeting of stockholders.